Effects of alirocumab on cardiovascular events after coronary bypass surgery

heading
Goodman, S.G., Aylward, P.E., Szarek, M., Viigimaa, M. et al.
statement of authorship
Goodman, Shaun G.; Aylward, Philip E.; Szarek, Michael; Chumburidze, Vakhtang; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg, Jay M.; Hanotin, Corinne; Harrington, Robert A.; Jukema, J. Wouter; Kedev, Sasko; Letierce, Alexia; Moryusef, Angele; Pordy, Robert; Lopez, Gabriel Arturo Ramos; Roe, Matthew T.; Viigimaa, Margus et al.
journal volume number month
vol. 74, 9
year of publication
pages
p. 1177−1186 : ill
keyword
alirocumab
coronary artery bypass graft
proprotein convertase subtilisin−kexin type (9PCSK9)
ISSN
0735-1097
notes
Includes bibliogr
availibility
ei leidu TTÜ Raamatukogus
TTÜ department code
ih
country
us
language
inglise
report field
aasta2019i
editor's notes
PMi 020720
Goodman, S.G., Aylward, P.E., Szarek, M., Viigimaa, M. et al. Effects of alirocumab on cardiovascular events after coronary bypass surgery // Journal of the American College of Cardiology (2019) vol. 74, 9, p. 1177−1186 : ill. https://doi.org/10.1016/j.jacc.2019.07.015